Skip to main content
Equibles

Leonteq Securities AG

Broker-Dealer

Position in PFE — Pfizer Inc

CIK 1535950 ZURICH, V8
Back to PFE Full portfolio

Position in PFE

as of Jun 30, 2026 · filed Jul 27, 2026
Position Value
$1,629,999
-$1,807,021 QoQ
Shares Held
67,691
-44.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,047
of 2,821 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Derivatives in PFE

reported options exposure · as of Jun 30, 2026
CallValue
$3,612,000
CallShares
150,000
PutValue
$9,632,000
PutShares
400,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Leonteq Securities AG holds $17,608,542 across 13 Drug Manufacturers - General names. PFE ranks #5 (9.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BIIB
Biogen Inc.
 21,354 $4,613,745
2 LLY
ELI LILLY & Co
 2,151 $2,579,974
3 GILD
Gilead Sciences, Inc.
 17,286 $2,183,913
4 JNJ
Johnson & Johnson
 7,758 $1,970,299
5 PFE
Pfizer Inc
This page 		67,691 $1,629,999
6 ABBV
AbbVie Inc.
 5,558 $1,398,615
7 NVO
Novo Nordisk A S
 28,796 $1,380,480
8 BMY
Bristol Myers Squibb Co
 12,628 $727,625

All Filings in PFE

Export CSV
43 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,629,999 67,691
2026-06-30 $9,632,000 400,000
2026-06-30 $3,612,000 150,000
2026-03-31 $11,232,000 400,000
2026-03-31 $4,212,000 150,000
2026-03-31 $3,437,020 122,401
2025-12-31 $14,940,000 600,000
2025-12-31 $18,809,883 755,417
2025-12-31 $3,737,490 150,100
2025-09-30 $11,730,686 460,388
2025-09-30 $10,192,000 400,000
2025-09-30 $2,548,000 100,000
2025-06-30 $26,226,637 1,081,957
2025-06-30 $14,544,000 600,000
2025-03-31 $3,801,000 150,000
2025-03-31 $11,806,716 465,932
2024-12-31 $4,085,620 154,000
2024-12-31 $11,682,644 440,356
2024-09-30 $4,456,760 154,000
2024-09-30 $13,721,119 474,123
2024-06-30 $10,406,965 371,943
2024-06-30 $2,798,000 100,000
2024-06-30 $2,798,000 100,000
2024-03-31 $6,937,500 250,000
2024-03-31 $2,221,720 80,062
2023-12-31 $12,963,100 450,264
2023-12-31 $31,669 1,100
2023-12-31 $10,076,500 350,000
2023-09-30 $4,116,231 124,095
2023-09-30 $11,609,500 350,000
2023-06-30 $11,069,877 301,796
2023-06-30 $12,838,000 350,000
2023-03-31 $379,154 9,293
2023-03-31 $8,160,000 200,000
2022-12-31 $7,697,529 150,225
2022-09-30 $7,535,296 172,196
2022-06-30 $4,640,893 88,516
2022-03-31 $5,498,905 106,218
2021-12-31 $13,449,405 227,763
2021-09-30 $1,304,579 30,332
2021-06-30 $6,521,275 166,529
2021-03-31 $10,096,938 278,690
2020-12-31 $11,084,190 301,119

Report a Problem

Category
Description
Email (optional, for follow-up)